Microvasculopathy in ischemic acute kidney injury: Consequences and therapeutic implications

Panminerva Medica

Volumn 54, Issue 1, 2012, Pages 45-52

  Patschan, D ^a   Patschan, S ^a   Muller G A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acute kidney injury; Cross infection; Mortality

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL; ARTICLE; ENDOTHELIUM CELL; HUMAN; ISCHEMIA; KIDNEY; KIDNEY CIRCULATION; MICROCIRCULATION; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY; STEM CELL TRANSPLANTATION; TRANSPLANTATION; VASCULARIZATION;

ACUTE KIDNEY INJURY; ANIMALS; ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; KIDNEY; MICROCIRCULATION; MICROVESSELS; RENAL CIRCULATION; STEM CELL TRANSPLANTATION;

EID: 84858802999     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Kribben A, Herget-Rosenthal S, Pietruck F, Philipp T. [Acute renal failure-an review], Deutsche Medizinische Wochenschrift (1946) 2003;128:1231-6. [Article in German]
2. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a populationbased study. Critical Care (London, England) 2005;9:R700-709.
3. Devarajan P. Update on mechanisms of ischemic acute kidney injury. JASN 2006;17:1503-20. (Pubitemid 43841396)
4. Wetzels JF, Yu L, Wang X, Kribben A, Burke TJ, Schrier RW. Calcium modulation and cell injury in isolated rat proximal tubules. J Pharmacol Exp Ther 1993;267:176-80. (Pubitemid 23325005)
5. Kribben A, Edelstein CL, Schrier RW. Pathophysiology of acute renal failure. J Nephrol 199912(Suppl 2):S 142-51.
6. Molitoris BA. New insights into the cell biology of ischemic acute renal failure. J Am Soc Nephrol 1991;1:1263-70.
7. Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Inte 2004;66:496-9. (Pubitemid 38981985)
8. Flores J, DiBona DR, Beck CH, Leaf A. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest 1972;51:118-26.
9. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2005;16:3315-25. (Pubitemid 46179335)
10. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109:e102-7.
11. Leaf A. Cell swelling. A factor in ischemic tissue injury. Circulation 1973;48:455-8.
12. Patschan D, Patschan S, Muller GA. Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence. Int J Nephrol 2011 2011:828369.
13. Patschan D, Plotkin M, Goligorsky MS. Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ca ira. Curr Opin Pharmacol 2006;6:176-83. (Pubitemid 43362132)
14. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM. The role of the complement system in ischemia-reperfusion injury. Shock 2004;21:401-9.
15. de Vries B, Kohl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P et al. Complement factor C5a mediates renal ischemiareperfusion injury independent from neutrophils. J Immunol 2003;170:3883-9. (Pubitemid 36359260)
16. Ren Y, Garvin JL, Liu R, Carretero OA. Cross-talk between arterioles and tubules in the kidney. Pediatr Nephrol 2009;24:31-5.
17. Sands JM, Layton HE. The Physiology of Urinary Concentration: An Update. Seminars in Nephrology 2009;29:178-195.
18. Loutzenhiser R, Griffin KA, Bidani AK. Systolic blood pressure as the trigger for the renal myogenic response: protective or autoregulatory? Curr Opin Nephrol Hypertens 2006;15:41-9.
19. Mori T, Shimizu T, Tani T. Septic acute renal failure. Contributions to Nephrology 2010;166:40-6.
20. Sheen MR, Kim JA, Lim SW, Jung JY, Han KH, Jeon US et al. Interstitial tonicity controls TonEBP expression in the renal medulla. Kidney Int 2009;75:518-25.
21. Rodrigues SM, LeDoux JE, Sapolsky RM. The influence of stress hormones on fear circuitry. Annu Rev Neurosci 2009;32:289-313.
22. Imig JD, Inscho EW, Deichmann PC, Reddy KM, Falck JR. Afferent arteriolar vasodilation to the sulfonimide analog of 11 12-epoxyeicosatrienoic acid involves protein kinase A. Hypertension 1999;33(1 Pt 2):408-13. (Pubitemid 29065693)
23. Bell TD, Welch WJ. Regulation of renal arteriolar tone by adenosine: novel role for type 2 receptors. Kidney Int 2009;75:769-71.
24. Harris RC, Zhang MZ, Cheng HF. Cyclooxygenase-2 and the renal renin-angiotensin system. Acta Physiol Scand 2004; 181:543-7. (Pubitemid 39078853)
25. Liu KL. Regulation of renal medullary circulation by the renin-angiotensin system in genetically hypertensive rats. Clin Exp Pharmacol Physiol 2009;36:455-61.
26. Thorin E, Webb DJ. Endothelium-derived endothelin-1. Pflugers Arch 2010;459:951-8.
27. Huang WC. Renal hemodynamic and tubular effects of angiotensins II and III. Chin J Physiol 1991;34:121-38.
28. Jaimes EA, Tian RX, Pearse D, Raij L. Up-regulation of glomerular COX-2 by angiotensin II:role of reactive oxygen species. Kidney Int 2005;68:2143-53. (Pubitemid 43117788)
29. Goligorsky MS. Endothelial cell dysfunction: can't live with it, how to live without it. American Journal of Physiology. Renal Physiology 2005;288:F871-880. (Pubitemid 40569751)
30. Andrews AM, Jaron D, Buerk DG, Kirby PL, Barbee KA. Direct, real-time measurement of shear stress-induced nitric oxide produced from endothelial cells in vitro. Nitric Oxide 2010;23:335-42.
31. Nakagawa T, Tanabe K, Croker BP, Johnson RJ, Grant MB, Kosugi T et al. Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol 2011;7:36-44.
32. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 2006;290:R1153-67.
33. Peti-Peterdi J, Harris RC. Macula densa sensing and signaling mechanisms of renin release. J Am Soc Nephrol 2010;21:1093-6.
34. Hellberg PO, Kallskog O, Wolgast M. Nephron function in the early phase of ischemic renal failure. Significance of erythrocyte trapping. Kidney Int 1990;38:432-9. (Pubitemid 20258745)
35. Mason J, Welsch J, Torhorst J. The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Int 1987;31:65-71. (Pubitemid 17006345)
36. Solez K, Kramer EC, Fox JA, Heptinstall RH. Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney Int 1974;6:24-37.
37. Hellberg PO, Bayati A, Källskog O, Wolgast M. Red cell trapping after ischemia and long-term kidney damage. Influence of hematocrit. Kidney Int 1990;37:1240-7. (Pubitemid 20148547)
38. Hellberg PO, Källskog OT, Ojteg G, Wolgast M. Peritubular capillary permeability and intravascular RBC aggregation after ischemia: effects of neutrophils. Am J Physiol 1990;258(4 Pt 2):F1018-25. (Pubitemid 20155516)
39. Rabb H, Mendiola CC, Dietz J, Saba SR, Issekutz TB, Abanilla F, Bonventre JV et al. Role of CD 11a and CD 11b in ischemic acute renal failure in rats. The Am J Physiol 1994;267:F1052-8. (Pubitemid 124005387)
40. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997;99:2682-90. (Pubitemid 27259815)
41. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008;1123:134-45. (Pubitemid 351431312)
42. Bazzoni G. and E. Dejana, Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiological reviews 2004;84:869-901. (Pubitemid 38823769)
43. Van Itallie CM, Anderson JM. Occludin confers adhesiveness when expressed in fibroblasts. J Cell Sei 1997;110(Pt 9): 1113-21. (Pubitemid 27232281)
44. Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B et al. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial Cadherin (VE-cadherin). J Cell Biol 1995;129:203-17.
45. Gopalakrishnan S, Dunn KW, Mans JA. Rac 1, but not RhoA, signaling protects epithelial adherens junction assembly during ATP depletion. Cell Physiol 2002;283:C261-72. (Pubitemid 34670570)
46. Yamamoto T, Tada T, Brodsky SV, Tanaka H, Noiri E, Kajiya F et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 2002;282:F1150-1155. (Pubitemid 34654481)
47. Asiedu-Gyekye IJ, Vaktorovich A. The., phenomenon in cerebral circulation. Med Sei Monit 2003;9(1 1):BR394-7.
48. Niccoli G, Kharbanda RK, Crea F, Banning AP. No-reflow: again prevention is better than treatment. Eur Heart J 2010;31:2449-55.
49. Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007;72:151-6. (Pubitemid 47067393)
50. Basile DP, Donohoe D Roethe K, Osbom JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001;281:F887-99.
51. Negri AL. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. J Nephrol 2004;17:496-503. (Pubitemid 39302876)
52. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008;19:2282-7.
53. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. American Journal of Physiology. Renal Physiology 2002;282:F1140-1149. (Pubitemid 34654480)
54. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7. (Pubitemid 27087709)
55. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Experimental Hematology 2007;35:1109-18. (Pubitemid 46921310)
56. Yoder MC, Ingram DA. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? Biochimica Et Biophysica Acta 2009; 1796:50-54.
57. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-9. (Pubitemid 46348173)
58. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research 1999;85:221-8. (Pubitemid 29377293)
59. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, Goligorsky MS. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am J Physiol Renal Physiol 2006;291:F176-185. (Pubitemid 43945948)
60. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005;289:F31-42. (Pubitemid 40863570)
61. Rehman J, Li J, Orschell CM, March KL. Peripheral blood, endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107:1164-9. (Pubitemid 36297209)
62. Goligorsky MS, Yasuda K, Ratliff B. Dysfunctional endothelial progenitor cells in chronic kidney disease. J Am Soc Nephrol 2010;21:911-9.
63. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-7. (Pubitemid 30036389)
64. Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtischerer S, Tonn T et al. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circulation Research 2007;100:1234-41. (Pubitemid 46684137)
65. Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R et al. Transcoronary transplantation of progenitor cells after myocardial infarction. The New England Journal of Medicine 2006;355:1222-32. (Pubitemid 44427446)
66. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004;109:1769-75. (Pubitemid 38500680)
67. Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 2002;106:1133-9. (Pubitemid 34970856)
68. Chen J, Li H, Addabbo F, Zhang F, Pelger E, Patschan D et al. Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence. The American Journal of Pathology 2009;174:701-11.
69. Carmona G, Chavakis E, Koehl U, Zeiher AM, Dimmeler S. Activation of Epac stimulates integrin-dependent homing of progenitor cells. Blood 2008; 111:2640-6.
70. Patschan D, Patschan S, Wessels JT, Becker JU, David S, Henze E et al. Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury. Am J Physiol Renal Physiol 2010;298:F78-85.
71. Perreau-Lenz S, Pévet P, Buijs RM, Kalsbeek A. The biological clock: the bodyguard of temporal homeostasis. Chronobiol Int 2004;21:1-25. (Pubitemid 38529226)
72. Reiter RJ, Tan D-X, Fuentes-Broto L. Melatonins multitasking molecule. Progress in Brain Res 2010;181:127-51.